Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials
Conclusion
Dual antithrombotic and NOAC regimens have reduced bleeding without compromising the risk of cardiovascular events or mortality, and should be preferred for patients with ACS or PCI also needing long-term anticoagulation.
Source: Coronary Artery Disease - Category: Cardiology Tags: Anti-platelet therapy Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Percutaneous Coronary Intervention | Vitamin K | Vitamins